Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias

Journal of the American College of Cardiology

Volumn 27, Issue 1, 1996, Pages 67-75

  Levine, Joseph H ^a   Massumi, Ali ^b   Scheinman, Melvin M ^c   Winkle, Roger A ^d   Platia, Edward V ^e   Chilson, Donald A ^f   Gomes, J Anthony ^g   Woosley, Raymond L ^h  

^a ST FRANCIS HOSPITAL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SEQUOIA HOSPITAL   (United States)

^e Washington Hospital   (United States)

^f Deaconess Hosp   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030025539     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00427-0     Document Type: Article

References (11)

1. Heger JJ, Prystowsky EN. Jackman WM, et al, Amiodarone: clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 1981;305:539-45.
2. Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 1976;38:934-44.
3. Podrid PJ. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyanhythmias. Am Heart J 1981;101:374-9.
4. Rakita L, Sobol SM. Amiodarone in the treatment of refractory ventricular arrhythmias. JAMA 1983;250:1293-5.
5. Kaski JC, Girolti LA, Messuti H, et al. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation 1981;64:273-9.
6. Marcus FI, Fontaine GH, Frank R. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone. Am Heart J 1981;101: 480-93.
7. Chapman J. Intravenous amiodarone in ventricular fibrillation. Br Med J 1981;282:951-2.
8. Leak D. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. Am Heart J 1986;111:456-62.
9. Mostow ND, Rakita L, Vrobel TR, et al. Amiodarone intravenous loading for rapid suppression of complex ventricular arrhythmias. J Am Coll Cardiol 1984;4:97-104.
10. Holt DW, Tucker GT, Jackson PR, Storey GCA. Amiodarone pharmacokinetics. Am Heart J 1983;106:840-7.
11. Kerin NZ, Blevins RD, Frumin H, et al. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. Am J Cardiol 1985;55:89-91.